Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5 Endometrial Neoplasms 5 Neoplasms 4 Head and Neck Neoplasms 3 Breast Neoplasms 3 Rectal Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Carcinosarcoma × dostarlimab × 90 days × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡